INSIGHTS

When Research Leaves You Out: How Geno.Me’s Britt Gottschalk is Changing the Clinical Trial Game
HealthX Team HealthX Team

When Research Leaves You Out: How Geno.Me’s Britt Gottschalk is Changing the Clinical Trial Game

For Britt Gottschalk, this gap in genetic data was more than just a footnote; it was a call to action. While consulting with clinical researchers at major universities and speaking with feasibility teams in pharma, she realized that the people most in need of cutting-edge treatments—often those in marginalized communities—were the least likely to be included in research. Determined to change that, Britt founded Geno.Me, a proprietary data exchange platform designed to democratize research by linking individuals’ genetic reports with their electronic health records while putting patients in control of when and how their data is used.

Read More
No More Telehealth Dead Ends: How KeyCare Unites Health Systems on One Seamless Platform
Kayla Liederbach Kayla Liederbach

No More Telehealth Dead Ends: How KeyCare Unites Health Systems on One Seamless Platform

When your child falls ill late at night, navigating multiple telehealth apps without access to their full medical history is frustrating. Meanwhile, health systems struggle with physician shortages and fragmented virtual care. The result? Longer waits, provider burnout, and missed care opportunities. KeyCare is aiming to solve this by integrating a network of virtual providers directly into Epic’s EHR platform.

Read More
Navigating the Art of the Exit: Insights from M&A Expert Nicolas Cindric
Kayla Liederbach Kayla Liederbach

Navigating the Art of the Exit: Insights from M&A Expert Nicolas Cindric

Exits can be both thrilling and daunting for founders in the healthcare ecosystem. That’s why HealthX Ventures recently hosted a session with Nicolas Cindric—an experienced M&A advisor, serial entrepreneur, and investor—to demystify the exit process and share actionable strategies.

Read More